IP Library Granted Patent US 11,473,078
Granted Patent B2
US 11,473,078 · App. 15/750,415 · Granted Oct 18, 2022

Artificial non-ribosomal peptide synthetases

Inventors: Claus-Peter Niesert (Seeheim-Jugenheim, DE); Helge B. Bode (Oberursel, DE); Kenan Bozhueyuek (Frankfurt am Main, DE); Florian Fleischhacker (Friedberg, DE)
Assignee: JOHANN WOLFGANG GOETHE-UNIVERSITAT
C12N9/93C12N15/1093C12P21/02C12Y603/02C40B40/06C40B40/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,473,078
App. No.
15/750,415
Granted
Oct 18, 2022
Kind
B2
Abstract

The present invention concerns a novel method for the modification and/or custom-made design of artificial non-ribosomal peptide synthetases (NRPSs) from naturally available NRPSs. The artificial NRPSs are of predetermined length and amino acid composition and sequence. Via fusion of well-defined NRPS units (so-called “exchange units”) in a certain manner, using a specific sequence motif in the linker areas it is possible to construct artificial and/or modified NRPS assembly lines, which have the ability of synthesizing peptides of a desired structure.

Claims (45)

1. A method of generating a non-ribosomal peptide synthetase (NRPS) comprising:

assembling an assembly of three or more exchange units (EU), said assembly including a first EU and a last EU, wherein each EU comprises an adenylation (A) domain followed by a thiolation (T) domain and a condensation (C) domain, wherein adjacent exchange units are connected by a linker (C-A linker) between the condensation (C) domain of an EU and the adenylation (A) domain of the adjacent EU and said C-A linker includes a consensus sequence Trp-Asn-Ala-Thr-Glu (SEQ ID NO: 1);

wherein each EU optionally further comprises an epimerization (E) domain, N-methylation (MT) domain, oxidation (Ox) domain, or other NRPS domain;

wherein the first EU of the assembly optionally further comprises an additional condensation (C) domain in front of the first adenylation (A) domain;

wherein the last EU is optionally an adenylation (A) domain, a thiolation (T) domain, or a thioesterase (TE) domain;

wherein within an individual EU the condensation (C) domain is optionally replaced by a heterocyclization (Cy) domain or a terminal condensation (C term ) domain; and

wherein said assembly optionally contains EUs from different species and adjacent C and A domains from different species have the same or similar substrate specificity.

2. The method of claim 1 , wherein the first EU of the assembly has an additional condensation (C) domain in front of the first A domain.

3. The method of claim 1 , wherein the last EU of the assembly is composed either of an A domain, a T domain, or a TE domain.

4. The method of claim 1 , wherein the last EU of the assembly is a TE domain.

5. The method of claim 4 , wherein the previous EU to the last EU of the assembly is composed of an A and a T domain.

6. The method of claim 1 , wherein in at least one EU a Cy domain or C term domain replaces the C domain.

7. The method of claim 1 , wherein in at least one EU an E, MT, or Ox domain is added to the EU.

8. The method of claim 1 , wherein the assembly of EU comprises EU domains derived from species of bacteria, fungi, and plants.

9. The method of claim 8 , wherein the substrate specificity of the C domain from one species and the substrate specificity of the A domain of the next EU from a different species is the same or is related.

10. The method of claim 1 , wherein assembling of the EUs is performed Gibson cloning or Yeast based TAR-cloning.

11. The method of claim 1 , wherein the NRPS contains polyketides (PKs) EUs or NRPS-PKS EUs.

12. The method of claim 1 , wherein the NRPS contains 3-10 EUs.

13. The method of claim 1 , wherein the NRPS contains 11-100 EUs.

14. The method of claim 8 , wherein said bacteria species are selected from Bacillus subtilis, Pseudomonas syringae, Streptomyces sp., or Escherichia coli . and wherein said fungi species are selected from yeast cells.

15. The method of claim 1 for the identification and production of peptides with activity as antibiotic, antifungal, antineoplastic agent, or immunosuppressant.

16. A kit comprising one or more genes each encoding a non-ribosomal peptide synthetase, wherein each of said one or more genes encodes an assembly of three or more exchange units (EU), said assembly including a first EU and a last EU, wherein each EU comprises an adenylation (A) domain followed by a thiolation (T) domain and a condensation (C) domain, wherein adjacent exchange units are connected by a linker (C-A linker) between the condensation (C) domain of an EU and the adenylation (A) domain of the adjacent EU and said C-A linker includes a consensus sequence Trp-Asn-Ala-Thr-Glu (SEQ ID NO: 1);

wherein each EU optionally further comprises an epimerization (E) domain, N-methylation (MT) domain, oxidation (Ox) domain, or other NRPS domain;

wherein the first EU of the assembly optionally further comprises an additional condensation (C) domain in front of the first adenylation (A) domain;

wherein the last EU is optionally an adenylation (A) domain, a thiolation (T) domain, or a thioesterase (TE) domain;

wherein within an individual EU the condensation (C) domain is optionally replaced by a heterocyclization (Cy) domain or a terminal condensation (C term ) domain; and

wherein said assembly optionally contains EUs from different species and adjacent C and A domains from different species have the same or similar substrate specificity.

17. A non-ribosomal peptide synthetase gene library comprising a plurality of genes encoding non-ribosomal peptide synthetases, wherein each gene encodes an assembly of at least 15 exchange units (EUs),

said assembly including a first EU and a last EU, wherein each EU comprises an adenylation (A) domain followed by a thiolation (T) domain and a condensation (C) domain, wherein adjacent exchange units are connected by a linker (C-A linker) between the condensation (C) domain of an EU and the adenylation (A) domain of the adjacent EU and said C-A linker includes a consensus sequence Trp-Asn-Ala-Thr-Glu (SEQ ID NO: 1);

wherein each EU optionally further comprises an epimerization (E) domain, N-methylation (MT) domain, oxidation (Ox) domain, or other NRPS domain;

wherein the first EU of the assembly optionally further comprises an additional condensation (C) domain in front of the first adenylation (A) domain;

wherein the last EU is optionally an adenylation (A) domain, a thiolation (T) domain, or a thioesterase (TE) domain;

wherein within an individual EU the condensation (C) domain is optionally replaced by a heterocyclization (Cy) domain or a terminal condensation (C term ) domain; and

wherein said assembly optionally contains EUs from different species and adjacent C and A domains from different species have the same or similar substrate specificity.

18. The non-ribosomal peptide synthetase gene library of claim 17 , wherein said each gene of said library encodes an assembly at least 25 EUs.

19. A non-ribosomal peptide synthetase gene of claim 17 , wherein said each gene of said library encodes an assembly of at least 50 EUs.

20. A non-ribosomal peptide synthetase gene library of claim 17 , wherein each gene of said library encodes an assembly of at least 100 EUs.

21. A non-ribosomal peptide synthetase gene library of claim 17 , wherein diversity is increased by random mutagenesis.

22. A method of generating a non-ribosomal peptide synthetase (NRPS) comprising a step of:

assembling an assembly having only two exchange units (EU), a first EU and a second EU, wherein each of the two exchange units comprises an adenylation (A) domain followed by a thiolation (T) domain and a condensation (C) domain, wherein the two exchange units are connected by a linker (C-A linker) between the condensation (C) domain of the first EU exchange units and the adenylation (A) domain of the second EU, and said C-A linker includes a consensus sequence Trp-Asn-Ala-Thr-Glu (SEQ ID NO: 1);

wherein each EU optionally further comprises an epimerization (E) domain, N-methylation (MT) domain, oxidation (Ox) domain, or other NRPS domain;

wherein the first EU of the assembly optionally further comprises an additional condensation (C) domain in front of the first adenylation (A) domain;

wherein the second EU is optionally an adenylation (A) domain, a thiolation (T) domain, or a thioesterase (TE) domain;

wherein within an individual EU the condensation (C) domain is optionally replaced by a heterocyclization (Cy) domain or a terminal condensation (C term ) domain; and

wherein said EUs are optionally from different species and adjacent C and A domains from different species have the same or similar substrate specificity.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2019
From: MERCK PATENT GMBH
To: JOHANN WOLFGANG GOETHE-UNIVERSITAT
Reel/Frame 051321/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2018
From: NIESERT, CLAUS-PETER; BOZHUEYUEK, KENAN; BODE, HELGE B.; FLEISCHHACKER, FLORIAN
To: MERCK PATENT GMBH
Reel/Frame 045177/0017 →
Priority Claims (1)
EP 15002340 · Aug 5, 2015 · regional
Continuity (1)
Related Publication 20180230449A1 · Aug 16, 2018
Cited By (1)
US 12,297,475